The global heart beat irregularity detection devices market is on a trajectory for substantial expansion, reveals a recent industry report. Projections indicate that by 2033, the market is poised to soar to USD 20.7 million, marking a noteworthy compound annual growth rate (CAGR) of 4.5% from its size of USD 13.4 million in 2023.
This surge is underpinned by the escalating demand for early detection of cardiac arrhythmias, a pivotal element in ensuring optimal patient care. Early identification of these irregularities enables prompt intervention, leading to enhanced patient outcomes.
Request a Report Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14396
The COVID-19 pandemic had a temporary impact on the market. While the initial focus on pandemic response shifted some resources away from other areas of healthcare, the overall demand for heart arrhythmia detection remained strong. In fact, the pandemic highlighted the importance of remote patient monitoring, potentially leading to an increased adoption of these devices in the future.
As COVID-19 cases decline and healthcare services resume normal operations, the market for heart beat irregularity detection devices is expected to experience a significant upswing. Healthcare providers are actively seeking ways to improve their ability to deliver medical care while monitoring patient progress remotely. This trend is expected to further propel the growth of this market.
Key Takeaways:
- The Holter monitor segment of the heart beat irregularity detection devices market was worth more than USD 2.8 billion in 2021, and it is predicted to expand significantly during the forecast period.
- During the analysis period, the tachycardia monitoring devices sector is expected to increase at a 6.8% CAGR based on application.
- By the end of the year, the heart beat irregularity detection devices market for resting ECG devices is expected to be worth more than USD 2.8 billion, with a CAGR of 4.6% during the projection period.
- The largest region, North America, has a high heart beat irregularity detection devices market attractiveness rating. By the end of the projected period, the heart beat irregularity detection devices market in this area is expected to be worth USD 2,900 Million.
- During the projection period, the mobile heart beat irregularity detection devices market sector is expected to increase at a substantial rate, with a CAGR of 8.4%.
- With a 5.8% CAGR, the ventricular fibrillation segment is expected to achieve a heart beat irregularity detection devices market worth over USD 2,500 Million.
- During the projection period in heart beat irregularity detection devices market, the hospitals segment is expected to develop at a high CAGR of 6.9%.
Visit for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-14396
Competitive Landscape:
- Philips agreed to buy Cardiology, a medical technology startup focusing on combining cloud technology and artificial intelligence to enhance heart diagnostics, in November 2021. (AI). This purchase expands the company’s heart beat irregularity detection devices product line, providing revenue growth potential in the market.
- The Federal Commission for the Protection against Sanitary Risk (COFEPRIS) gave AliveCor permission to launch KardiaMobile in Mexico in February 2020. The business has teamed up with Inpharamo to roll out the medical-grade ECG across the United States. As a result, the firm has been able to extend its global reach as well as its client base.
Key Companies Profiled:
- Alive Cor
- Applied Cardiac Systems
- Biotronik
- Biotricity
- GE Healthcare
- iRhythm Technologies
- Koninklijke Philips N.V.
- Medtronic plc.
- Nihon Kohden Corporation
- St. Jude Medical (Abbott Laboratories)
- Welch Allyn (Hillrom Services, Inc.)
- NUUBO Smart Solutions Technologies, SL
- Spacelabs Healthcare, Inc. (OSI Systems, Inc.)
- Fukuda Denshi Co., Ltd.
- Schiller AG
- Mortara Instrument Inc.
- BPL Medical Technologies
- Lepu Medical Technology(Beijing) Co., Ltd
Key Segments Covered in Heart Beat Irregularity Detection Device Industry Research:
Devices:
- Holter Monitor
- Event Recorder
- Mobile Cardiac Telemetry
- Implantable Cardiac Monitor
- Electrocardiogram
- Others
Applications:
- Tachycardia
- Atrial Tachycardia
- Ventricular Tachycardia
- Bradycardia
- Premature Contraction
- Others
End-User:
- Hospitals and Clinics
- Diagnostic Centers
- Ambulatory Surgical Centers
- Homecare Settings
- Others
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
Purchase Now to Access: https://www.futuremarketinsights.com/checkout/14396
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
